Test for early detection of cervical cancer.
Total Health | June 1st, 2009
Zetiq Technologies, a subsidiary of Bio-Light, has successfully completed the first arm of its cervicalRelating either to the cervix (the neck of the womb) or to the cervical vertebrae in the neck (cervical spine). cancerAbnormal, uncontrolled cell division resulting in a malignant tumour that may invade surrounding tissues or spread to distant parts of the body. clinical trial, aimed at identifying and diagnosing cervical cancer in biopsies. The goal of the trial was to demonstrate and measure the ability of Zetiq's technology to accurately diagnose the presence of cervical cancer cells and the stage of the disease, including in early stages of malignancy, in cervical biopsies. Read the full story on the Bio-Light website
Filed under:
Expert articles
Related videos
Recent news
Expert articles
Related news


